The Problem: Each year in the US, hospital-acquired infection accounts more for than 99,000 deaths (Preventing Health-Care Associated Infection, CDC). The human body regulates the number of microbes in and on the body, which are mostly beneficial. When an implantable device is placed in the body, the body cannot control the surface of the material, enabling for proliferation of bacteria-producing factories (called biofilms) that leads to infection. Antibiotics are co-administered with implantable devices to combat infection; however, their over use kills many of the beneficial microbes and gives rise to antibiotic-resistant microbes also known as superbugs.
Hydrophilix Solution: When implantable devices are coated with the Hydrophilix coating, a thin hydration layer prevents pathogens from adhering to the device surface and proliferating into biofilms. Because the coating does not kill microbes, the creation of superbugs is avoided.